Srilatha Simhadri

发表

Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists.

M. Webb, I. Henderson, J. Saunders, 2008, Bioorganic & medicinal chemistry letters.

ATR/ATM-Mediated Phosphorylation of BRCA1 T1394 Promotes Homologous Recombinational Repair and G2–M Checkpoint Maintenance

Xiaochun Yu, Joonyoung Her, S. Bunting, 2021, Cancer Research.

Mice Disrupted BRCA 1-PALB 2 Interaction in Male Fertility Defect Associated with Molecular Bases of Disease :

T. Ludwig, Shaun E. Peterson, S. Ganesan, 2014 .

Male Fertility Defect Associated with Disrupted BRCA1-PALB2 Interaction in Mice*

T. Ludwig, Shaun E. Peterson, S. Ganesan, 2014, The Journal of Biological Chemistry.

Benzo[a]pyrene diol epoxide-deoxyguanosine adducts are accurately bypassed by yeast DNA polymerase zeta in vitro.

D. Jerina, J. M. Sayer, D. Hinkle, 2002, Mutation research.

Evidence of Intertissue Differences in the DNA Damage Response and the Pro-oncogenic Role of NF-κB in Mice with Disengaged BRCA1-PALB2 Interaction.

S. Ganesan, Yanying Huo, B. Xia, 2018, Cancer research.

Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists.

Maria L Webb, Michael Snider, Zahid Hussain, 2006, Bioorganic & medicinal chemistry letters.

PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response

S. Ganesan, G. Oakley, C. Sørensen, 2018, Oncogene.

Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance

S. Ganesan, Zhiyuan Shen, B. Xia, 2017, eLife.

Compromised BRCA1-PALB2 interaction is associated with breast cancer risk

W. Foulkes, J. Reis-Filho, B. Weigelt, 2017, Oncogene.

Requirement of Heterogeneous Nuclear Ribonucleoprotein C for BRCA Gene Expression and Homologous Recombination

J. Ule, J. König, Jianglin Ma, 2013, PloS one.

BRAF Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in BRAFV600E Mutant Melanoma

E. White, S. Ganesan, Siraj M. Ali, 2017, Clinical Cancer Research.

BRAF fusion as a novel mechanism of acquired resistance to vemurafenib in BRAF V 600 E mutant 3 melanoma 4 5

E. White, S. Ganesan, Siraj M. Ali, 2017 .

Protein-lysine methyltransferases G9a and GLP1 promote responses to DNA damage

S. Ganesan, Ming Yao, A. Kulkarni, 2017, Scientific Reports.

BRAF Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in BRAF Mutant Melanoma

S. Ganesan, A. Kulkarni, J. Mehnert, 2017 .

Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries.

Maria L Webb, M. Webb, I. Henderson, 2006, Biochemical and biophysical research communications.